Prevalence of type 2 diabetes mellitus in patients with chronic kidney disease in nizhnii novgorog region


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Aim. Assessment of prevalence of diabetes mellitus (DM) type 2 in patients with chronic kidney disease (CKD) in Nizhnii Novgorod region. Methods. 1051 CKD patients, consulted in Regional clinical hospital and City of Nizhnii Novgorod center of nephrology in 2008-20і3, were included into the study. Results of clinical and laboratory investigation were submitted into the Nizhnii Novgorod CKD registry. Results. dm type 2 is і5,6 % among all the causes of CKD in Nizhnii Novgorod region. 72 % of all patients with dm had CKd stage 2. Microalbuminuria was found mostly often after 5 years, proteinuria - after 10 years after dm manifestation. Conclusion. Diabetes mellitus type 2 is one of the leading causes of chronic kidney disease in Nizhnii Novgorog region

全文:

受限制的访问

参考

  1. Дедов И.И., Шестакова М.В. Сахарный диабет: диагностика, лечение, профилактика. - М.: ООО «Медицинское информационное агентство». - 2011. - C. 94-95.
  2. Donnelly R., Emslie-Smith A.M. Vascular complication of diabetes // BMJ. - 2000. - Vol. 15(320). - P. 1062-1066.
  3. Маслова О.В., Сунцов Ю.И., Шестакова М.В. и др. Распространенность поражения почек при сахарном диабете 1 и 2 типов в Российской Федерации // Сахарный диабет. - 2009. - № 4. - С. 48-51.
  4. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease //Am. J. Kidney Dis. - 2007. - Vol. 49 (Suppl. 2). - P. 1-180.
  5. Шестакова М.В. Современное понятие «Хроническая болезнь почек»: методы диагностики, клиническое значение// Сахарный диабет. - 2008. - № 2. - С. 4-7.
  6. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification // Am. J. Kidney Dis. - 2002. - Vol. 39. - P. 1-286.
  7. Шестакова М.В. Сахарный диабет и хроническая болезнь почек: современная диагностика и лечение// Вестник РАМН. - 2012. - № 1. - С. 45-49.
  8. Шестакова М.В., Дедов И.И. Сахарный диабет и хроническая болезнь почек. - М.: ООО «Медицинское информационное агентство». - 2009. - С. 15-30.
  9. Cederholm J., Eliasson B. et al. For the steering committee of the Swedish National Diabetes Register. Microalbuminuria and risk factors in type 1 and type 2 diabetic patients // Diabetes Research and Clinical Practice. - 2005. - Vol. 67. - P. 258-266.
  10. Parving H.-H., Lewis J.B. et al. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global prespective // Kidney Int. - 2006. - Vol. 69(11). - P. 2057-2063.
  11. Jermendy G., Ruggenenti P. Preventing microalbuminuria in patients with type 2 diabetes// Diabetes/Metabolism. - 2007. - Vol. 23(2). - P. 100-110.
  12. Viberti, G. Regression of albuminuria: latest evidence for a new approach // J. Hypertens. - 2003. - Vol. 21. - P. 24-28.
  13. The Diabetes Control and Complications Research Group: Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes control and Complications Trial// Kidney Int. - 1995. - Vol. 47. - P. 1703-1720.
  14. Дедов И.И., Шестакова М.В. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. - М. - 2013. - C. 45-52.
  15. Pierrat A., Gravier E., Saunders C. et al. Predicting GFR in children and adults: a comparison of the Cockcroft-Gault, Schwartz and Modification of Diet in Renal Disease formulas // Kidney Int. - 2003. - Vol. 64. - P. 1425-1436.
  16. Vervoort G., Willems H.L., Wetzels J.F. Assessment of glomerular filtration rate in healthy subjects and and normoalbuminuric diabetic patients: validity of a new (MDRD)prediction equation//Nephrol. Dial. Transplant. - 2002. - Vol. 17. - P. 1909-1913

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##